Blepharitis
MONDO:0004785Inflammation of the eyelids near the eyelashes.
Also known as: eyelid inflammation, inflammation of eyelid
28 clinical trials for this condition and its sub-types, 11 tagged with Blepharitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Blepharitis
-
Parasitic eyelid infestation 0 trials · 9 incl. sub-types
1 sub-type
- Filarial elephantiasis 9 trials
-
Hordeolum 1 trial · 7 incl. sub-types
2 sub-types
- Internal hordeolum 1 trial · 6 incl. sub-types Sub-types →
- Hordeolum externum 0 trials
-
Blepharoconjunctivitis 2 trials
3 sub-types
- Angular blepharoconjunctivitis 0 trials
- Contact blepharoconjunctivitis 0 trials
- Giant papillary conjunctivitis 0 trials
-
Noninfectious dermatoses of eyelid 0 trials · 1 incl. sub-types
4 sub-types
- Eczematous dermatitis of eyelid 1 trial
- Allergic contact dermatitis of eyelid 0 trials
- Discoid lupus erythematosus of eyelid 0 trials
- Xeroderma of eyelid 0 trials
-
Squamous blepharitis 0 trials
-
Ulcerative blepharitis 0 trials
Most studied deeper sub-types
-
Light therapy for stubborn eyelid lumps? tiny trial ends early
Disease control Stopped earlyThis study tested whether intense pulsed light (IPL) can help treat chalazion, a common eyelid lump. Only 4 adults with a fresh chalazion were enrolled, and the trial was stopped early. Because of the very small size, we cannot say if IPL works or is safe for this condition.
Sponsor: Lumenis Be Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New eye ointment aimed at soothing chronic eyelid inflammation
Disease control Stopped earlyThis study tested a medicated ointment called pimecrolimus 0.3% for people with blepharitis, a condition that causes red, irritated eyelids. The trial planned to include 477 participants aged 2 and older, applying the ointment twice daily to the eyelid margins. The main goal was …
Phase 3 • Sponsor: Famy Life Sciences, a Viatris Company • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC